Scott K. Howell

Metformin reduces systemic methylglyoxal levels in type 2 diabetes.

Paul J. Beisswenger, Scott K. Howell, Allison D. Touchette et al. · Diabetes · 1999 · 443 citations

Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes

Nazeer Ahmed, Roya Babaei‐Jadidi, Scott K. Howell et al. · Diabetologia · 2005 · 238 citations · Full text

Diabetes Management, Biochemistry, Clinical Type 1 +10

Susceptibility to Diabetic Nephropathy Is Related to Dicarbonyl and Oxidative Stress

Paul J. Beisswenger, Keith Drummond, Robert G. Nelson et al. · Diabetes · 2005 · 188 citations · Full text

Metabolic Syndrome, Renal Function, Individual Susceptibility +14

Human Fructosamine-3-Kinase

Benjamin S. Szwergold, Scott K. Howell, Paul J. Beisswenger · Diabetes · 2001 · 168 citations · Full text

Protein Function, Nonenzymatic Glycation, Biochemistry +10

α-Dicarbonyls Increase in the Postprandial Period and Reflect the Degree of Hyperglycemia

Paul J. Beisswenger, Scott K. Howell, Rita M. O’Dell et al. · Diabetes Care · 2001 · 163 citations · Full text